MOST SHARED
- The Executive Job Search
- Chinese Overcapacity is Worsening, EU Chamber Warns
- Salvation Army's Kettles Now Credit Card-Ready
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Gold Retreats from New High Above $1,194
- Wal-Mart Price Pressure Hurts China Workers: Report
- Oil Friday
- Hyundai-Kia Targets Rapid China Growth in 2010
- China Unveils Carbon Target Ahead of Copenhagen
- Fannie Mae to Tighten Lending Standards: Report
- Share Trading on London Stock Exchange Resumes
- China Overcapacity Worsening, EU Chamber Warns
- Investing in Good Karma – and Making a Profit
- UK Retail Sales Pick Up in Nov., Strong Dec. Seen
- Black Friday to Avoid Red Ink; Greenback Gets the Blues
- Wal-Mart Price Pressure Hurts China Workers: Report
- Bankruptcies Jump, Hitting Highest Level in Four Years
- Steepest Black Friday Discounts, Revealed
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Revenge of the Gangsta Nerds
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
DUBLIN, Oct 30, 2009 (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/7fe655/wyeth_performance) has announced the addition of the "Wyeth: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market" report to their offering.
A strategic assessment of Wyeth, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.
Contains 121 pages and 14 tables Key Topics Covered: I. Executive Summary II. Business Organization III. Senior Management IV. Facilities and Employees V. Technological Know-How VI. Product Portfolio VII. Marketing Tactics VIII. Sales and Profit Growth IX. R&D Expenditures and Major Programs X. Collaborative Arrangements XI. Strategic Direction For more information visit http://www.researchandmarkets.com/research/7fe655/wyeth_performance SOURCE: Research and Markets CONTACT: Research and Markets Laura Wood, Senior Manager, press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2009 -0- INDUSTRY KEYWORD: Health
Pharmaceutical


